INS and central nervous system disorder: The GA group had higher prevalence of ASA class III and IV patients (91.14% vs 90.04%), COPD (10.51% vs 9.51%), diabetes on insulin (9.69% vs 8.64%), and central nervous system disease (43.33% vs 41.18%) than RA group (Table 2).